Beta This is a new service and it is still being tested. Tell us about a problem.

Parliament's record since 1997: debates, questions, statements, votes, bills, committees and members' interests

Where MPs Stand

Sourced briefings on the record of Parliament

Blood, tissue and organ screening

Inquiry by the Science and Technology Committee (Commons), 30 November 2013 to 17 October 2014. Its page on the Parliament website.

Reports and responses

Evidence sessions

  • 5 February 2014: Mark Ward and Joseph Peaty, Secretary and Head of Publicity, TaintedBlood, Liz Carroll, Chief Executive, Haemophilia Society, Dr Matthew Buckland, Chair, Medical Advisory Panel, UK Primary Immunodeficiency Network, and Consultant Immunologist, Barts Health NHS Trust, and Christine Lord; Professor Marc Turner, Chair, Advisory Committee on the Safety of Blood, Tissues and Organs Prion Group, and Chair, UK Blood Services Prion Working Group, Dr Roland Salmon, Acting Chair, Advisory Committee on Dangerous Pathogens, and Dr Sheila MacLennan, Professional Director, UK Blood Services Joint Professional Advisory Committee
  • 5 March 2014: Dr Steven Burton, Chief Executive, ProMetic Biosciences Ltd, Dr Kelly Board, Technical Specialist, DuPont Chemicals and Fluoroproducts, Dr Alex Raeber, Head of Research and Development, Prionics AG, Nigel Talboys, Global Director of Blood Safety and EMEA Director of Public Policy and Government Affairs, Terumo BCT, and Professor John Collinge, Director, MRC Prion Unit and Professor of Neurology at the UCL Institute of Neurology.
  • 26 March 2014: Professor Richard Knight, Director, National CJD Research and Surveillance Unit, Professor Sheila Bird, Programme Leader, Medical Research Council Biostatistics Unit, Dr Paula Bolton-Maggs, Medical Director, Serious Hazards of Transfusion (SHOT) Haemovigilance Scheme, Dr Simon Mead, Association of British Neurologists
  • 28 April 2014: Dr Richard Baker, Executive Committee Member, British Transplantation Society, Dr Mike Knapton, Associate Medical Director (Prevention & Care), British Heart Foundation, Ed Owen, Chief Executive, Cystic Fibrosis Trust, and Keith Rigg, Chair, Transplant 2013
  • 30 April 2014: Professor James Neuberger, Associate Medical Director, NHS Blood and Transplant, Dr Lorna Williamson, Medical and Research Director, NHS Blood and Transplant, Dr Paul Cosford, Director for Health Protection and Medical Director, Public Health England, and Dr Katy Sinka, Consultant Epidemiologist and Head of CJD Section, Public Health England; Jane Ellison MP, Parliamentary Under-Secretary of State for Public Health, Department of Health, and Professor Dame Sally Davies, Chief Medical Officer, Department of Health